Alto Partners and Arca Fondi acquire pharma manufacturer Eurosirel

Milan-based private equity firm Alto Partners and Italian fund management company Arca Fondi have agreed to the buyout of Eurosirel, a manufacturer and distributor of medical devices and cosmetics. The transaction is expected to close by June. 

As part of the transaction, Alto’s latest fund, Alto Capital V, and Arca’s private equity fund, Arca Space Capital, will acquire Eurosirel from the company’s founders, Ernesto and Alberto Leonelli, through an equally owned and managed special-purpose entity.

Get the week’s top news delivered directly to your inbox – Sign up for our newsletter
Sign up

The acquisition is intended to support Eurosirel’s international growth with a focus on research and development, technology and proprietary solutions.

Alto Partners and Arca Fondi were advised by OC&C, Giovannelli Studio Legale, Spada Partners and ERM. Ernesto Leonelli was advised by Marcianesi & Associati and Orrick.

Read more:Private Equity Wire

Can’t stop reading? Read more